TY - JOUR
T1 - Endoscopic tri-modal imaging is more effective than standard endoscopy in identifying early-stage neoplasia in Barrett's esophagus
AU - Curvers, Wouter L.
AU - Herrero, Lorenza Alvarez
AU - Wallace, Michael B.
AU - Wong Kee Song, Louis Michel
AU - Ragunath, Krish
AU - Wolfsen, Herbert C.
AU - Prasad, Ganapathy A.
AU - Wang, Kenneth K.
AU - Subramanian, Venkataraman
AU - Weusten, Bas L.A.M.
AU - Ten Kate, Fiebo J.
AU - Bergman, Jacques J.G.H.M.
PY - 2010/10
Y1 - 2010/10
N2 - Background & Aims Endoscopic tri-modal imaging (ETMI) incorporates high-resolution endoscopy (HRE), autofluorescence imaging (AFI), and narrow band imaging (NBI). A recent uncontrolled study found that ETMI improved the detection of high-grade dysplasia (HGD) and early carcinoma (Ca) in Barrett's esophagus (BE). The aim was to compare ETMI with standard video endoscopy (SVE) for the detection of HGD/Ca with the use of a randomized cross-over design. Methods Patients referred for work-up of inconspicuous HGD/Ca were eligible and underwent both SVE and ETMI in randomized order within an interval of 612 weeks. During ETMI, inspection with HRE was followed by AFI. Detected lesions were inspected in detail with NBI and biopsied, followed by random biopsies. During SVE, any visible lesion was biopsied followed by random biopsies. Results Eighty-seven patients with BE underwent ETMI and SVE. No significant difference was observed in overall histologic yield between ETMI and SVE. ETMI had a significantly higher targeted yield compared with SVE because of AFI. However, the yield of targeted biopsies of ETMI was significantly inferior to the overall yield of SVE. Detailed inspection with NBI reduced the false-positive rate of HRE + AFI from 71% to 48% but misclassified 17% of HGD/Ca lesions as not suspicious. Conclusions ETMI statistically significant improves the targeted detection of HGD/Ca compared with SVE. Subsequent characterization of lesions with NBI appears to be of limited value. At this stage, ETMI cannot replace random biopsies for detection of lesions or targeted biopsies for characterization of lesions in a high-risk population.
AB - Background & Aims Endoscopic tri-modal imaging (ETMI) incorporates high-resolution endoscopy (HRE), autofluorescence imaging (AFI), and narrow band imaging (NBI). A recent uncontrolled study found that ETMI improved the detection of high-grade dysplasia (HGD) and early carcinoma (Ca) in Barrett's esophagus (BE). The aim was to compare ETMI with standard video endoscopy (SVE) for the detection of HGD/Ca with the use of a randomized cross-over design. Methods Patients referred for work-up of inconspicuous HGD/Ca were eligible and underwent both SVE and ETMI in randomized order within an interval of 612 weeks. During ETMI, inspection with HRE was followed by AFI. Detected lesions were inspected in detail with NBI and biopsied, followed by random biopsies. During SVE, any visible lesion was biopsied followed by random biopsies. Results Eighty-seven patients with BE underwent ETMI and SVE. No significant difference was observed in overall histologic yield between ETMI and SVE. ETMI had a significantly higher targeted yield compared with SVE because of AFI. However, the yield of targeted biopsies of ETMI was significantly inferior to the overall yield of SVE. Detailed inspection with NBI reduced the false-positive rate of HRE + AFI from 71% to 48% but misclassified 17% of HGD/Ca lesions as not suspicious. Conclusions ETMI statistically significant improves the targeted detection of HGD/Ca compared with SVE. Subsequent characterization of lesions with NBI appears to be of limited value. At this stage, ETMI cannot replace random biopsies for detection of lesions or targeted biopsies for characterization of lesions in a high-risk population.
KW - Autofluorescence Imaging
KW - Endoscopy
KW - Esophageal Adenocarcinoma
KW - Narrow Band Imaging
UR - http://www.scopus.com/inward/record.url?scp=77957359387&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77957359387&partnerID=8YFLogxK
U2 - 10.1053/j.gastro.2010.06.045
DO - 10.1053/j.gastro.2010.06.045
M3 - Article
C2 - 20600033
AN - SCOPUS:77957359387
SN - 0016-5085
VL - 139
SP - 1106-1114.e1
JO - Gastroenterology
JF - Gastroenterology
IS - 4
ER -